3
2
1

Significant Achievements: Successfully Cultivated Human Heart in Pigs, Bringing New Hope for Organ Transplantation

2025/06/19

Recently, the world's top - tier academic journal Nature featured a major research achievement by Chinese scientists on its front - page headlines. For the first time, a heart containing human cells was cultivated in a pig embryo, and this heart could beat autonomously and survived for 21 days. This groundbreaking progress offers a brand - new solution to the global shortage of organ transplants and marks a new stage in the development of xenogeneic organ cultivation technology.

Bountiful Harvest: A Review of Life Extension Plan Scientific Achievements

2025/02/07

With the rapid development of science and technology, humanity's exploration of life has never ceased. During the 2023-2024 period, we witnessed a series of exciting scientific achievements. These not only made significant progress in fields such as anti-aging, gene editing, organ regeneration, and immunotherapy but also pointed the way for future medical research.

The 2024 World's Top Ten Scientific and Technological Advances Announced, with Significant Achievements in Life Sciences

2025/02/07

Recently, the "2024 China/World Top Ten Scientific and Technological Advances" organized by the Chinese Academy of Sciences and the Chinese Academy of Engineering was unveiled. In the list of the world's top ten scientific advancements, breakthroughs in cell and gene technologies stood out, including the first 3D-printed functional human brain tissue, CAR-T therapy, gene editing, Google's new quantum chip, super microscope, and more.

Milestone! World's First Ovarian Dual Activation Technology Assists Patients in Conception

2025/01/15

ecently, a major breakthrough in the field of reproductive health has garnered wide attention. The "ovarian dual activation" technology, collaboratively developed by the Yinfeng Life Sciences Research Institute (referred to as "Yinfeng Life Sciences") and the team of Professor Wang Huiying and Dr. Jin Bo from the Shenzhen Hospital of Beijing University of Chinese Medicine (referred to as "the hospital"), has achieved another milestone in cryobiomedical technology. Using methods of "cryopreservation + PFC", this technology has helped two patients achieve natural conception, providing new hope for women of childbearing age who are cancer patients, infertile, or of advanced maternal age.

2025-06-27

Scientists Breakthrough in Key Technology for 3D - Printed Organs: Rapid Generation of Vascular Networks

Recently, the team led by Alison Marsden from Stanford University in the United States published a significant breakthrough in the journal Science. They successfully developed a computational model that can rapidly design the vascular network for 3D - printed organs. This technology is expected to greatly reduce the manufacturing time of artificial organs and offer new solutions to the problem of organ transplantation shortage.

2025-06-27

Harvard's New Technology: Ultra - Flexible Brain - Computer Interface Enables Live Streaming of Brain Development

In June 2025, the team led by Liu Jia from Harvard University published a groundbreaking study in the journal *Nature*. They developed an ultra - flexible brain - computer interface device, which for the first time achieved non - invasive, high - resolution recording of neural electrical activities during the development of the vertebrate embryonic brain. This opens up a new way to understand the brain construction mechanism and the origin of neurodevelopmental diseases.

2025-06-19

Milestone! A Chinese Scientist Team Unveils a New Approach to Anti - aging and Lifespan Extension

Recently, the research group led by Liu Guanghui from the Institute of Zoology, Chinese Academy of Sciences, in collaboration with the teams of Wang Si from Xuanwu Hospital, Capital Medical University, and Qu Jing from the Institute of Zoology, Chinese Academy of Sciences, published a significant research paper in the journal Cell. This study delved deep into the aging regulatory mechanism and used synthetic biology methods to reprogram the longevity gene pathway. As a result, engineered human anti - aging mesenchymal progenitor cells (SRC) with triple resistance to aging, stress, and malignant transformation were successfully constructed.

2025-06-19

Significant Achievements: Successfully Cultivated Human Heart in Pigs, Bringing New Hope for Organ Transplantation

Recently, the world's top - tier academic journal Nature featured a major research achievement by Chinese scientists on its front - page headlines. For the first time, a heart containing human cells was cultivated in a pig embryo, and this heart could beat autonomously and survived for 21 days. This groundbreaking progress offers a brand - new solution to the global shortage of organ transplants and marks a new stage in the development of xenogeneic organ cultivation technology.

2025-06-13

A Blockbuster in Science! U.S. Discovers a Switch to Reverse Diabetes, Offering Hope for Treatment

A groundbreaking study published in the international top - tier journal Science in February this year may bring revolutionary hope to hundreds of millions of type 2 diabetes patients worldwide. The team of scientists from the University of Michigan in the United States not only uncovered a core secret of diabetes onset but, even more excitingly, they successfully reversed the damage, which may completely transform the diabetes treatment model.

2025-06-13

Anticancer Black Technology BNCT: Blasting Tumors in 30 Minutes and Opening a New Chapter in Precision Cancer Treatment

Recently, Yin Ye, the CEO of BGI Group, shared some exciting anticancer news on video channels such as "Liao Yibo Caijing", which sparked heated discussions on WeChat Moments. He mentioned that Japan has recently launched a cutting - edge cancer treatment technology known as the "seventh chariot", called BNCT, which is translated into Chinese as Boron Neutron Capture Therapy.

2025-06-12

FDA's Groundbreaking Reform: Will AI Gradually Replace Animal Testing? Where Is the Future of Drug Safety Evaluation Heading?

A policy adjustment by the US FDA has stirred up quite a storm in the pharmaceutical R & D industry. Recently, the FDA announced that in the development of drugs such as monoclonal antibodies, it will gradually reduce, optimize, or replace animal testing, and instead rely on AI - based toxicity models, cell lines, and organoid tests. The simultaneously released "Roadmap for Reducing Animal Testing in Pre - clinical Safety Studies" further outlines a strategic vision for gradually moving away from dependence on animals.

2025-06-05

Advances in Cryoprotectants: Antifreeze Peptide AVD Effectively Inhibits Ice Crystal Damage with 95.7% Cell Recovery Rate

Recently, a research team from Tianjin University published a study in Engineering, designing a novel antifreeze peptide, AVD, by mimicking the "molecular Lego" of Antarctic bacterial antifreeze proteins. Experiments show that frozen cells supplemented with AVD achieved a recovery rate of up to 95.7%, tripling the efficiency of conventional methods.

2025-04-25

New Flexible Auditory Brainstem Implant Offers Hope for Patients with Severe Hearing Loss

A research team from the Swiss Federal Institute of Technology Lausanne (EPFL) recently published a groundbreaking achievement in Nature Biomedical Engineering: the world’s first flexible auditory brainstem implant (ABI). This innovative technology aims to address the side effects caused by the rigid structure of traditional ABIs, offering a more precise and safe hearing restoration solution for patients with severe cochlear nerve damage who cannot benefit from cochlear implants.

2025-04-25

Nature Medicine Review: AI Reconstructs the Paradigm of Drug Development

In the prolonged battle between humanity and disease, drug development remains the decisive battleground. Faced with the harsh reality of an average investment of $2.6 billion, a 15-year timeline, and a success rate below 10%, global scientists are turning to artificial intelligence (AI). This disruptive technology is quietly ushering drug development into a new era of "algorithm-driven" innovation. By 2025, the latest research in Nature journals reveals that generative AI models, exemplified by ChatGPT and Sora, are reshaping the entire drug development pipeline—from target discovery to clinical trials—accelerating "AI-driven drug discovery" from concept to clinical practice.

< 1234...10 >